Webinar: ACR/CHEST ILD Guidelines in Practice| Video: COVID in the Rear View

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Opinion

Subcategories:Patient PerspectiveProfilesRheuminationsSpeak Out RheumVideo

In Memoriam … Joseph D. Croft Jr., MD

  |  

We recently learned the sad news that Joseph D. Croft Jr., MD, a past president of the ACR and a well-respected member of the rheumatology community passed away in late September.

In Memoriam … Sheldon Mark Cooper, MD, MACR

Bonita Libman, MD  |  

Sheldon Mark Cooper, MD, MACR, professor of medicine, and a colleague and mentor throughout my career at the University of Vermont, Burlington, passed away June 6, after a long illness. Dr. Cooper was born in The Bronx, New York, in 1942, earning his medical degree from New York University School of Medicine in 1967. He…

Ellen M. Gravallese, MD, Now an APLAR Master

  |  

As the Asia-Pacific League of Associations for Rheumatology (APLAR) convened its 26th annual congress in Singapore this August, Ellen M. Gravallese, MD, was honored as an APLAR Master. Dr. Gravallese is currently the Theodore Bevier Bayles Professor of Medicine at Harvard Medical School, Boston, chief of the Division of Rheumatology, Inflammation and Immunity at Brigham…

Let’s Define Undifferentiated Connective Tissue Disease

Lucy Masto, BS, Medha Barbhaiya, MD, MPH, Caroline H. Siegel, MD, MS, Lisa R. Sammaritano, MD, & Michael D. Lockshin, MD  |  

Undifferentiated connective tissue disease (UCTD) is a diagnosis given to patients who do not fulfill current classification criteria for named connective tissue diseases (CTD)—systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), systemic sclerosis (SSc), or Sjögren’s disease—but who nonetheless have clinical signs and symptoms and serological evidence of autoimmune CTDs. In 1980 LeRoy et al. were…